Workflow
万邦医药：回购股份方案已实施完毕
Anhui Wanbang Pharmaceutical Technology Anhui Wanbang Pharmaceutical Technology (SZ:301520) Zheng Quan Ri Bao Wang·2025-10-23 13:13

Group 1 - The core point of the article is that Wanbang Pharmaceutical (301520) has completed its share repurchase plan, which was set to expire on October 22, 2025 [1] - The company repurchased a total of 404,900 shares, which represents 0.61% of its total share capital [1]